As reported by Mint, Biocon revenue up 16% but profit hit by loss of licensing. Licensing is surely important source of revenue generation. Biocon’s net profit has declined which is due to loss of licensing income from Pfizer, Divestment of Axicorp stake and licensing income from other partners such as Mylan Inc. Biocon and [...]
On 26th April 2012, we wish all readers happy and innovative “World IP Day”. Keeping the spirit of “visionary innovators” IIPTA has conducted series of IP workshops across various pharmaceutical and biotechnology colleges in India. Main aim of the workshop was to make students – the future innovators aware about intellectual property. [...]
Overview:The Controller General of Patents, Designs and Trade Marks has given a compulsory license to Hyderabad based Natco a local drug maker to manufacture and sell its generic version of German multinational Bayer’s patent-protected cancer medicine, Nexavar (Sorafenib tosylate), at about 30 times lower than charged by its Bayer Corporation. Detailed Analysis: On Monday [...]
In 2006 Novartis had sued Indian Government for not granting patent to its anti cancer drug Imatinib selling under brand name ” Glivec“. It also challenged the constitutional validity of section 3 d of Indian Patent Act 1970 which says new forms including esters, ethers, acids or other derivatives of known substance are not [...]
A top UK scientist who helped sequence the human genome has said efforts to patent the first synthetic life form would give its creator a monopoly on a range of genetic engineering. Colonies of the transformed Mycoplasma mycoides bacterium. Image Credit: J. Craig Venter Institute. For the first time, the controversial geneticist credited with [...]
The last two decades saw geographical indications (GIs) often being put into the center-stage in many multilateral and bilateral trade talks. There have been demands by the European Union (EU) and many developing countries to grant higher protection for products other than wines and spirits at the Protection of GIs refers to protection of [...]
